# Chronic Lymphocytic Leukemia — 5-Minute Journal Club: Microlearning Activity 3 Page: https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-3 Text version: https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-3.md Podcast: [Hematologic Oncology Update](https://stenobird.com/podcast/hematologic-oncology-update-916423) Published: 2026-09-06T12:00:00+00:00 Episode link: https://hematologic-oncology.captivate.fm/episode/5961-cllmicro2025-5mjc-3 Audio file: https://dts.podtrac.com/redirect.mp3/episodes.captivate.fm/episode/a01d0b0e-8405-4c09-a3fb-3b6d9e6c1f33.mp3 Processing state: not_requested JSON: https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-3 Duration seconds: 1378 ## Resource Featuring perspectives from Prof John Seymour, including the following topics: Safety of fixed-duration acalabrutinib/venetoclax for chronic lymphocytic leukemia (CLL) (0:00) Venetoclax re-treatment and ongoing trials with acalabrutinib/venetoclax for CLL (6:21) First-line treatment with sonrotoclax and zanubrutinib for CLL (13:10) CME information and select publications ## Actions - request_transcript: `POST https://stenobird.com/v1/public/podcasts/hematologic-oncology-update-916423/episodes/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-3/transcription-requests` — Idempotently request low-priority transcript generation for this episode. - read_markdown: `GET https://stenobird.com/podcast/hematologic-oncology-update-916423/chronic-lymphocytic-leukemia-5-minute-journal-club-microlearning-activity-3.md` — Read the agent-friendly Markdown representation of this episode resource. A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed. ## Transcript Full transcripts are not published on public pages unless there is a clear rights basis.